Smoking Cessation Intervention for Reducing Cigarette Use
Trial Summary
What is the purpose of this trial?
This clinical trial evaluates the effectiveness of active episodic future thinking (EFT) stimuli for reducing cigarette consumption in cigarette smokers. EFT is an innovative framing method shown to significantly activate brain regions involved in future thinking, planning, and other executive functions. Active EFT stimuli are positive events, unrelated to smoking, that participants anticipate, look forward to, and can vividly imagine happening up to 1 year in the future. Control EFT stimuli are positive past events, unrelated to smoking, that participants can vividly remember happening in the recent past. Active EFT stimuli may help reduce cigarette consumption among cigarette smokers by exposing them to personally relevant future oriented stimuli.
Will I have to stop taking my current medications?
The trial requires that you are not currently using nicotine replacement therapy, bupropion, or varenicline. If you are using these, you would need to stop before participating.
What data supports the effectiveness of the treatment for smoking cessation?
Research shows that Episodic Future Thinking (EFT), which involves imagining positive future events, can reduce cigarette craving and delay discounting (the tendency to prefer smaller immediate rewards over larger future ones), which are both linked to smoking behavior. This suggests that EFT may help people quit smoking by making them less impulsive and reducing their desire to smoke.12345
Is episodic future thinking (EFT) safe for use in smoking cessation interventions?
How is the Smoking Cessation Intervention (EFT) different from other smoking cessation treatments?
The Smoking Cessation Intervention using Episodic Future Thinking (EFT) is unique because it involves imagining future scenarios to reduce cigarette use, which is different from traditional methods like nicotine replacement or counseling. This approach focuses on changing how individuals think about their future, potentially making it a novel way to address smoking habits.89101112
Research Team
Christine Sheffer
Principal Investigator
Roswell Park
Eligibility Criteria
This trial is for cigarette smokers who smoke at least 10 cigarettes daily, do not use other tobacco products regularly, have a smartphone with texting ability, and can vividly imagine visual images. People using nicotine replacements or certain medications, those who've used drugs of abuse recently, or live with someone in the study cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the active or control EFT stimulus and use the iCOquit Smokerlyzer carbon monoxide monitor
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Medical Device Usage and Evaluation
- Smoking Cessation Intervention
- Smoking Cessation Intervention (control)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Roswell Park Cancer Institute
Lead Sponsor